Critical role of insulin‑like growth factor binding protein‑5 in methamphetamine‑induced apoptosis in cardiomyocytes
Ka-Pui Leung1, Yi-Hong Qu1, Dong-Fang Qiao1
1Department of Forensic Medicine, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Abstract:
Methamphetamine (MA) is a highly abused amphetamine‑like psychostimulant. At present, the mechanisms underlying MA‑induced cardiotoxicity are poorly understood. The cardiotoxic effects have yet not been clearly elucidated with respect to the apoptotic pathway. Insulin‑like growth factor binding protein‑5 (IGFBP5) is important for cell growth control and the induction of apoptosis. The aim of the present study was to analyze whether IGFBP5 is involved in MA‑induced apoptosis as a novel target. MA‑induced apoptosis was observed in neonatal rat ventricular myocytes (NRVMs) in a concentration‑dependent manner using a terminal deoxyribonucleotide transferase‑mediated dUTP nick end‑labeling assay. Using reverse transcription polymerase chain reaction and western blotting, MA was demonstrated to induce concentration‑dependent increases in the expression of IGFBP5. Silencing IGFBP5 with small interfering RNA significantly reduced apoptosis and suppressed the expression of caspase‑3 in NRVMs following treatment with MA. To the best of our knowledge, the present study provided the first evidence suggesting that IGFBP5 is a potential therapeutic target in MA‑induced apoptosis in vitro, providing a foundation for future in vivo studies.
Insights
This study reveals that Insulin-like growth factor binding protein-5 (IGFBP5) plays a key role in methamphetamine-induced cardiotoxicity. Inhibiting IGFBP5 significantly reduced heart cell death, suggesting it as a potential therapeutic target.
Area of Science:
- Cardiology
- Toxicology
- Molecular Biology
Background:
- Methamphetamine (MA) abuse causes cardiotoxicity, but the underlying mechanisms, particularly apoptosis, remain unclear.
- Insulin-like growth factor binding protein-5 (IGFBP5) is implicated in cell growth and apoptosis.
- Understanding MA's impact on cardiac cells is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of IGFBP5 in methamphetamine-induced cardiotoxicity.
- To determine if IGFBP5 is a potential therapeutic target for MA-induced heart damage.
- To elucidate the specific apoptotic pathways involved.
Main Methods:
- Neonatal rat ventricular myocytes (NRVMs) were treated with varying concentrations of MA.
- Apoptosis was assessed using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay.
- IGFBP5 expression was analyzed via reverse transcription polymerase chain reaction (RT-PCR) and Western blotting.
- IGFBP5 was silenced using small interfering RNA (siRNA) to evaluate its effect on MA-induced apoptosis and caspase-3 expression.
Main Results:
- Methamphetamine induced apoptosis in NRVMs in a concentration-dependent manner.
- MA treatment led to increased expression of IGFBP5 in a concentration-dependent manner.
- Silencing IGFBP5 significantly reduced MA-induced apoptosis and suppressed caspase-3 expression.
- These findings suggest IGFBP5 is a mediator of MA cardiotoxicity.
Conclusions:
- This study provides the first evidence that IGFBP5 is involved in methamphetamine-induced apoptosis in vitro.
- IGFBP5 emerges as a potential therapeutic target for mitigating MA-induced cardiotoxicity.
- Further in vivo studies are warranted to validate these findings and explore therapeutic strategies.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
